Hca Healthcare, INC Form 4 insider transactions

Michael S. Cuffe, EVP and Chief Clinical Officer of HCA Healthcare, sold 6,311 shares of common stock at an average price of $316.8792 on May 9, 2024.

Jeffrey E. Cohen, SVP-Government Relations at HCA Healthcare, sold 1,650 shares of common stock at $313 per share on May 9, 2024.

Group President Erol R. Akdamar reports a transaction involving HCA Healthcare, Inc. common stock, including a gift and adjustments to holdings in family trusts and an LLC.

EVP and Chief Clinical Officer of HCA Healthcare, Michael S. Cuffe, reports multiple transactions involving company stock, including acquisitions, disposals, and a stock appreciation right exercise.

Kathryn A. Torres, SVP at HCA Healthcare, reported the sale of company stock on May 2nd and 3rd, 2024.

Thomas F. Frist III, a director at HCA Healthcare, reported acquiring 1,284 shares of common stock due to a director equity award and shares received in lieu of cash retainers.

Director William R. Frist reports acquisition of HCA Healthcare stock and details extensive indirect beneficial ownership through various entities and trusts.

Director Andrea B. Smith reports the acquisition of 610 shares of HCA Healthcare common stock and indirect ownership of 82 shares through managed accounts.

Director Wayne Joseph Riley acquired 610 shares of HCA Healthcare, Inc. common stock through an annual director equity award.

Director Michael Michelson reports acquiring and disposing of HCA Healthcare common stock related to restricted share units.

Director Hugh F. Johnston reported acquiring and disposing of HCA Healthcare common stock on April 29, 2024, according to a Form 4 filing with the SEC.

Director Nancy Ann DeParle acquired 610 shares of HCA Healthcare common stock through an annual director equity award.

Director Robert J. Dennis acquired 963 shares of HCA Healthcare, Inc. common stock on April 29, 2024, through an equity award and in lieu of a cash retainer.

Director Meg Crofton received 610 shares of HCA Healthcare common stock as part of an annual director equity award.

Michael R. McAlevey, EVP Chief Legal & Admin Off at HCA Healthcare, reports acquisition of stock appreciation rights.

Mike Marks, EVP and CFO of HCA Healthcare, reports the acquisition of stock appreciation rights and a gift of common stock.

Chad Wasserman, SVP and CIO of HCA Healthcare, exercised stock appreciation rights and sold shares of common stock under a pre-arranged Rule 10b5-1 trading plan.